# Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor

> **NCT00733733** · PHASE3 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 180 (estimated)

## Conditions studied

- Renal Transplant Patients
- Recipients of a Kidney From a Non-Heart-Beating Donor

## Interventions

- **DRUG:** ATG Fresenius

## Key facts

- **NCT ID:** NCT00733733
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2010-01
- **Final completion:** 2010-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2008-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733733, "Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00733733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*